日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prevalence of alternative lengthening of telomeres in pediatric sarcomas determined by the telomeric DNA C-circle assay

通过端粒 DNA C 环分析确定儿童肉瘤中端粒替代延长的患病率

Trevor A Burrow, Balakrishna Koneru, Shawn J Macha, Wenyue Sun, Frederic G Barr, Timothy J Triche, C Patrick Reynolds

Piperacetazine Directly Binds to the PAX3::FOXO1 Fusion Protein and Inhibits Its Transcriptional Activity

哌拉西嗪直接与 PAX3::FOXO1 融合蛋白结合并抑制其转录活性

Kay Nakazawa #, Taryn Shaw #, Young K Song, Marilyn Kouassi-Brou, Anna Molotkova, Purushottam B Tiwari, Hsien-Chao Chou, Xinyu Wen, Jun S Wei, Emre Deniz, Jeffrey A Toretsky, Charles Keller, Frederic G Barr, Javed Khan, Aykut Üren

Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis

新型 GLCCI1-BRAF 融合在嗜铬细胞瘤病中驱动激酶信号传导

Benjamin L Green, Robert R C Grant, Christopher T Richie, Bishwanath Chatterjee, Michelly Sampaio De Melo, Frederic G Barr, Karel Pacak, Sunita K Agarwal, Naris Nilubol

NanoString Digital Molecular Profiling of Protein and microRNA in Rhabdomyosarcoma

横纹肌肉瘤中蛋白质和 microRNA 的 NanoString 数字分子分析

Atif A Ahmed, Midhat S Farooqi, Sultan S Habeebu, Elizabeth Gonzalez, Terrie G Flatt, Ashley L Wilson, Frederic G Barr

Serine hydroxymethyltransferase 2 expression promotes tumorigenesis in rhabdomyosarcoma with 12q13-q14 amplification

丝氨酸羟甲基转移酶 2 表达促进 12q13-q14 扩增的横纹肌肉瘤发生

Thanh H Nguyen, Prasantha L Vemu, Gregory E Hoy, Salah Boudjadi, Bishwanath Chatterjee, Jack F Shern, Javed Khan, Wenyue Sun, Frederic G Barr

A Fusion Transcription Factor-Driven Cancer Progresses to a Fusion-Independent Relapse via Constitutive Activation of a Downstream Transcriptional Target

融合转录因子驱动的癌症通过下游转录靶标的组成性激活进展为融合独立的复发

Salah Boudjadi, Puspa Raj Pandey, Bishwanath Chatterjee, Thanh Hung Nguyen, Wenyue Sun, Frederic G Barr

Evidence of pioneer factor activity of an oncogenic fusion transcription factor

致癌融合转录因子先锋因子活性的证据

Benjamin D Sunkel, Meng Wang, Stephanie LaHaye, Benjamin J Kelly, James R Fitch, Frederic G Barr, Peter White, Benjamin Z Stanton

Phenotypic profiling with a living biobank of primary rhabdomyosarcoma unravels disease heterogeneity and AKT sensitivity

利用原发性横纹肌肉瘤活体生物库进行表型分析揭示疾病异质性和 AKT 敏感性

Gabriele Manzella, Leonie D Schreck, Willemijn B Breunis, Jan Molenaar, Hans Merks, Frederic G Barr, Wenyue Sun, Michaela Römmele, Luduo Zhang, Joelle Tchinda, Quy A Ngo, Peter Bode, Olivier Delattre, Didier Surdez, Bharat Rekhi, Felix K Niggli, Beat W Schäfer #, Marco Wachtel #

CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive Rhabdomyosarcoma

CDK4 扩增降低了融合阳性横纹肌肉瘤对 CDK4/6 抑制的敏感性

Mary E Olanich, Wenyue Sun, Stephen M Hewitt, Zied Abdullaev, Svetlana D Pack, Frederic G Barr

A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations

MYOD1 中的复发性新形态突变定义了与 PI3K-AKT 通路突变相关的具有临床侵袭性的胚胎横纹肌肉瘤亚群

Shinji Kohsaka, Neerav Shukla, Nabahet Ameur, Tatsuo Ito, Charlotte K Y Ng, Lu Wang, Diana Lim, Angela Marchetti, Agnes Viale, Mono Pirun, Nicholas D Socci, Li-Xuan Qin, Raf Sciot, Julia Bridge, Samuel Singer, Paul Meyers, Leonard H Wexler, Frederic G Barr, Snjezana Dogan, Jonathan A Fletcher, Jorge